Serina Therapeutics Statistics
Total Valuation
SER has a market cap or net worth of $24.38 million. The enterprise value is $24.65 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SER has 12.31 million shares outstanding. The number of shares has increased by 38.47% in one year.
| Current Share Class | 12.31M |
| Shares Outstanding | 12.31M |
| Shares Change (YoY) | +38.47% |
| Shares Change (QoQ) | +3.14% |
| Owned by Insiders (%) | 10.54% |
| Owned by Institutions (%) | 3.51% |
| Float | 6.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 187.55 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 189.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71
| Current Ratio | 1.71 |
| Quick Ratio | 0.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -112.78 |
Financial Efficiency
Return on equity (ROE) is -8,159.24% and return on invested capital (ROIC) is -739.23%.
| Return on Equity (ROE) | -8,159.24% |
| Return on Assets (ROA) | -219.58% |
| Return on Invested Capital (ROIC) | -739.23% |
| Return on Capital Employed (ROCE) | -709.03% |
| Weighted Average Cost of Capital (WACC) | 4.82% |
| Revenue Per Employee | $10,000 |
| Profits Per Employee | -$1.50M |
| Employee Count | 13 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SER has paid $18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.71% in the last 52 weeks. The beta is 0.10, so SER's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -60.71% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 3.87 |
| Relative Strength Index (RSI) | 48.17 |
| Average Volume (20 Days) | 9,543,715 |
Short Selling Information
The latest short interest is 110,517, so 0.90% of the outstanding shares have been sold short.
| Short Interest | 110,517 |
| Short Previous Month | 91,712 |
| Short % of Shares Out | 0.90% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 1.40 |
Income Statement
In the last 12 months, SER had revenue of $130,000 and -$19.44 million in losses. Loss per share was -$1.91.
| Revenue | 130,000 |
| Gross Profit | -13.03M |
| Operating Income | -24.02M |
| Pretax Income | -19.20M |
| Net Income | -19.44M |
| EBITDA | -23.95M |
| EBIT | -24.02M |
| Loss Per Share | -$1.91 |
Full Income StatementBalance Sheet
The company has $3.06 million in cash and $3.32 million in debt, with a net cash position of -$267,000 or -$0.02 per share.
| Cash & Cash Equivalents | 3.06M |
| Total Debt | 3.32M |
| Net Cash | -267,000 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -37,000 |
| Book Value Per Share | -0.46 |
| Working Capital | 2.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.96 million and capital expenditures -$59,000, giving a free cash flow of -$18.01 million.
| Operating Cash Flow | -17.96M |
| Capital Expenditures | -59,000 |
| Depreciation & Amortization | 73,000 |
| Net Borrowing | 4.91M |
| Free Cash Flow | -18.01M |
| FCF Per Share | -$1.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -18,478.46% |
| Pretax Margin | -14,766.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SER does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.47% |
| Shareholder Yield | -38.47% |
| Earnings Yield | -79.71% |
| FCF Yield | -73.88% |
Analyst Forecast
The average price target for SER is $15.00, which is 657.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 657.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -9.76% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SER has an Altman Z-Score of -19.46 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.46 |
| Piotroski F-Score | 3 |
